Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183230 · ClinicalTrials.gov registry record · NA
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
A NA study of Depression and Suicidal Ideation, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 2
- Study locations
NCT05183230 is a NA study of Depression and Suicidal Ideation that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 115 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05183230, a NA study of Depression and Suicidal Ideation, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).
Conditions Studied
Interventions
- BEHAVIORAL WellPATH-PREVENT
- BEHAVIORAL Optimized WellPATH-PREVENT
Study Locations (2)
New York
- New York Presbyterian Hospital/Weill Cornell Medicine - New York
- Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05183230
The ClinicalTrials.gov registry entry for NCT05183230 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which WellPATH-PREVENT is the first listed.
NCT05183230 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05183230 about?
NCT05183230 is a clinical study titled "WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt". The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a ...
What is the current status of trial NCT05183230?
This trial is currently recruiting. It is a NA study. The enrollment target is 115 participants. The study started on 2022-04-22. Estimated completion is 2026-09-30.
What conditions does trial NCT05183230 study?
This clinical trial studies the following conditions: Depression, Suicidal Ideation, Suicide, Attempted.
What interventions are being tested in trial NCT05183230?
The interventions under investigation include: WellPATH-PREVENT (BEHAVIORAL), Optimized WellPATH-PREVENT (BEHAVIORAL).
Who is sponsoring clinical trial NCT05183230?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05183230 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.